Where Vaccine Policy Fails the Injured
As lawsuits challenge RFK Jr.’s vaccine policy changes, a deeper issue remains overlooked: the lack of a functioning compensation system for people injured by COVID-19 vaccines.
Secretary Kennedy’s changes at HHS regarding vaccines have sparked lawsuits from various organizations and entities while COVID-19 vaccine injury compensation remains broken and untouched by his administration. Over the past several months, the national conversation about vaccines has been dominated by political battles, legal challenges, and rapidly shifting federal policy.
Courts are now being asked to determine how far the Secretary of Health and Human Services can go in reshaping vaccine policy. Medical organizations are filing lawsuits. Federal agencies are defending sweeping changes to vaccine recommendations and the structure of federal vaccine advisory committees.
But amid all of this conflict, one group remains largely invisible in the debate: the people who were injured by vaccines and are still waiting for meaningful compensation.
That gap—between political fights over vaccine policy and the reality facing vaccine-injured individuals—is becoming increasingly difficult to ignore.
For readers unfamiliar with how vaccine injury claims are handled in the United States, I previously explained how the federal Vaccine Injury Compensation Program works and why it was created in the first place.
A Federal Court Is Now Testing the Limits of Vaccine Policy Authority
A major lawsuit now unfolding in federal court could determine how much power the Secretary of Health and Human Services has to reshape vaccine policy in the United States.
According to reporting by STAT News on March 4, 2026, the U.S. Department of Justice argued that Health and Human Services Secretary Robert F. Kennedy Jr. has broad authority to determine what scientific evidence and expert opinions he relies on when making vaccine policy decisions.
The case was brought by the American Academy of Pediatrics and several other medical organizations challenging Kennedy’s changes to federal vaccine policy.
The dispute centers on two major developments:
• Changes to the Advisory Committee on Immunization Practices (ACIP), the panel that typically reviews vaccine evidence and makes national immunization recommendations.
• The removal of the COVID-19 vaccine from the childhood vaccine schedule.
These decisions are particularly significant because federal vaccine recommendations often influence liability protections, coverage rules, and eligibility for the Vaccine Injury Compensation Program, which I explain in detail here.
Who Gets to Decide What Counts as Scientific Evidence?
The administration’s legal argument goes even further.
According to KFF Health News on March 5, 2026, government lawyers argued that determining what qualifies as valid public health evidence is ultimately within the authority of the Department of Health and Human Services itself.
In other words, HHS leadership has the discretion to decide:
• which studies to consider
• which experts to consult
• how competing evidence should be evaluated
That argument raises a fundamental question now sitting before the federal courts:
If HHS unequivocally decides what evidence counts, who ensures that vaccine policy remains grounded in established scientific review?
The answer matters because vaccine policy decisions have consequences that extend far beyond advisory committees. They shape liability protections, regulatory policy, and the compensation systems available to injured individuals.
Medical Groups Say the Policy Changes Were Arbitrary
The plaintiffs challenging the policy changes argue that the administration violated federal administrative law.
Under the Administrative Procedure Act, federal agencies must engage in “reasoned decision-making” when implementing policy changes.
The medical organizations argue that HHS selectively consulted scientific advisory committees for some decisions while bypassing them entirely for others.
According to the plaintiffs, that inconsistency amounts to arbitrary and capricious policymaking, which federal courts have the authority to review.
Vaccine Policy Changes Are Drawing Political Scrutiny
The legal challenge is unfolding as Kennedy’s vaccine policy changes face growing scrutiny in Washington.
According to Politico Pulse on March 4, 2026, the administration’s overhaul of vaccine policy has become one of the most controversial aspects of the federal health agenda.
Changes to vaccine recommendations, advisory committees, and immunization schedules have triggered criticism from major medical organizations and raised concerns among lawmakers about the scientific basis for the decisions.
But while Washington debates regulatory authority and scientific process, one critical issue remains largely absent from the discussion.
The People Missing From the Entire Debate
The people who were injured by vaccines.
When Congress created the National Vaccine Injury Compensation Program (VICP) in 1986, it did so based on a simple principle:
Vaccines benefit society as a whole, but rare injuries can occur. When they do, those individuals deserve compensation.
The program was designed as a no-fault system to ensure that injured individuals would not have to pursue traditional civil litigation against vaccine manufacturers.
For readers unfamiliar with why civil lawsuits are so difficult in vaccine cases, I previously explained why most vaccine injury claims cannot be pursued in traditional civil courts.
COVID Vaccine Injury Claims Expose a Broken System
The problem becomes even clearer when examining COVID-19 vaccine injuries.
Unlike routine childhood vaccines, COVID vaccines fall under the Public Readiness and Emergency Preparedness (PREP) Act, which places injury claims within the Countermeasures Injury Compensation Program (CICP).
The CICP differs significantly from the traditional Vaccine Injury Compensation Program.
It provides:
• limited transparency
• no traditional court hearings
• extremely limited judicial review
I previously explained the key differences between these two systems in a separate post.
Thousands of COVID vaccine injury claims have been filed, yet only a small number have resulted in compensation.
Despite that reality, the national policy debate about vaccines rarely addresses the individuals navigating this compensation system.
The Conversation We Should Be Having
The United States has long recognized a basic public health principle:
If society encourages widespread vaccination for the public good, it must also provide a fair system to compensate the small number of individuals who are injured.
That principle is not political.
It is about accountability.
Debates about vaccine policy will continue. Courts will weigh the limits of executive authority. Federal agencies will defend their decisions.
But none of those disputes should obscure the central obligation underlying vaccine policy in the United States.
If the government promotes vaccines, it must also take care of the people who are harmed by them.
Right now, that obligation is missing from the national conversation.
And until it returns, vaccine policy will continue to fail the very people it was designed to protect.
Stay Informed
This newsletter focuses on vaccine injury law, vaccine policy, and the compensation systems that exist for injured individuals.
If you want to follow developments in vaccine litigation, federal policy, and compensation programs, you can subscribe below.